![]() Since this is a symptomatic athlete with arrhythmias who needs the most optimal treatment, we recommended an electrophysiological study and ablation of symptomatic atrial fibrillation. ![]() Severe nocturnal bradycardia at 39 beats per minute (physiological sinus bradycardia indicating good recovery).Īfter the medical study supported by artificial intelligence and assessment by our team of cardiologists, we came to the following conclusion and solution of the problem:.Ventricular extrasistols (advanced beating of the ventricles) and two episodes of non-sustained ventricular tachycardia, one of which coincided with the symptom diary event referred to as "heart flip" on 8/10 at 17:05h.Supraventricular tachycardias during races, some of them with atrial fibrillation criteria.We detected some relevant arrhythmias responsible for the symptoms she described: Her heart rate during recovery after exertion, throughout the day, and during sleep was also studied. ![]() With these variables and the analysis of the sports holter that she wore, we started looking for a "Why?" to her situation.ĭuring this 10-day cardiac monitoring, we analyzed 759,131 heartbeats and cardiac adaptation to different types of physical activity, including competition and training. February 2019: heart rates of 197 beats per minute maintained for 40 minutes and occasional palpitations during exercise.She has completed Ironman competitions, crossed the Gibraltar Strait in 2015, won the Madrid-Segovia in MTB in 2018. High-intensity sports practice for 14 years: Weekly sessions of more than 12-15 hours ( sports cardiologists consider more than 13 hours per week as high performance).Close relative with atrial fibrillation at age 55: She has a close family history.This uncertainty about her heart caused Patricia to withdraw from competing because she couldn’t find an answer to the problems she had.īefore going into detail on how we discovered Patricia’s heart problem, we want to explain her athletic background. and none of the tests had found a solution. She has spent her entire life in sports, from rhythmic gymnastics to swimming (she swam across the Strait of Gibraltar in 2015), passing through medium-distance triathlon and mountain biking.įor several years, Patricia had felt discomfort in her heart when her pulse reached high rates during training and competitions, highlighting several periods in which her heart remained pumping at 180-190 pulsations after a strenuous activity.īefore putting herself in our hands, Patricia had already tried everything: stress tests, traditional holters, magnetic resonance of the heart. Patricia could be considered a semi-pro athlete. ![]() Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.Patricia's case was a challenge for us nonetheless, we have analyzed, studied and resolved her atrial fibrillation. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. ![]() The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. With a substantial impact on morbidity and mortality, the growing “epidemic” of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |